These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 6302734)

  • 1. [Sonographic diagnosis in primary cancer of the liver].
    Räth U; Johnson PJ; Williams R
    Radiologe; 1983 Mar; 23(3):108-13. PubMed ID: 6302734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgically treated cases of mixed hepatocellular carcinoma and cholangiocarcinoma.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1083-6. PubMed ID: 12143207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].
    Tischoff I; Tannapfel A
    Zentralbl Chir; 2007 Aug; 132(4):300-5. PubMed ID: 17724632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
    Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
    J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A resected case of a small hepatocellular carcinoma developing within the bile duct.
    Yasui O; Sato T; Andoh H; Kurokawa T; Watanabe D; Sageshima M; Nanjo H
    J Hepatobiliary Pancreat Surg; 2004; 11(3):193-6. PubMed ID: 15235893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of hepatocyte paraffin 1 antibody in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma and metastatic carcinoma.
    Shiran MS; Isa MR; Sherina MS; Rampal L; Hairuszah I; Sabariah AR
    Malays J Pathol; 2006 Dec; 28(2):87-92. PubMed ID: 18376797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Das-1 immunostain is useful for discriminating metastatic colon adenocarcinoma from cholangiocarcinoma and hepatocellular carcinoma.
    Zimmerman RL; Das KM; Fogt F; Burke M; Murakata LA
    Oncol Rep; 2002; 9(6):1369-72. PubMed ID: 12375050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrasonic characteristics of the small hepatocellular carcinoma.
    Makuuchi M; Hasegawa H; Yamazaki S; Bandai Y; Watanabe G; Ito T
    Ultrasound Med Biol; 1983; Suppl 2():489-91. PubMed ID: 6100711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ultrasonic diagnosis of liver tumors--with special reference to its limitations in predicting histology].
    Makuuchi M
    Gan To Kagaku Ryoho; 1984 May; 11(5):1122-33. PubMed ID: 6326686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
    Lei JY; Bourne PA; diSant'Agnese PA; Huang J
    Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of combined hepatocellular and cholangiocarcinoma.
    Kassahun WT; Hauss J
    Int J Clin Pract; 2008 Aug; 62(8):1271-8. PubMed ID: 18284443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Sonographic diagnosis of hepatocellular carcinoma. Results of a retrospective study 1983-1989].
    Reuss J; Seitz K
    Ultraschall Med; 1989 Jun; 10(3):111-4. PubMed ID: 2549627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis and treatment of primary liver cancer].
    Nikhinson RA
    Vopr Onkol; 1984; 30(5):82-4. PubMed ID: 6328763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
    Pitman MB; Triratanachat S; Young RH; Oliva E
    Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression of cytokeratins 7, 19, and 20 in primary and metastatic carcinomas of the liver.
    Maeda T; Kajiyama K; Adachi E; Takenaka K; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 1996 Sep; 9(9):901-9. PubMed ID: 8878022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic value of cytokeratins and carcinoembryonic antigen immunostaining in differentiating hepatocellular carcinomas from intrahepatic cholangiocarcinomas.
    Stroescu C; Herlea V; Dragnea A; Popescu I
    J Gastrointestin Liver Dis; 2006 Mar; 15(1):9-14. PubMed ID: 16680226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathologic features and risk factors for hepatocellular carcinoma: results from a single center in southern Turkey.
    Ozer B; Serin E; Yilmaz U; Gümürdülü Y; Saygili OB; Kayaselçuk F; Boyacioğlu S
    Turk J Gastroenterol; 2003 Jun; 14(2):85-90. PubMed ID: 14614632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Isolated tumor cells in primary malignant liver tumors].
    Tannapfel A; Geissler F; Witzigmann H; Wittekind C
    Zentralbl Chir; 2000; 125(7):602-5. PubMed ID: 10960969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double cancer, cholangiocellular and hepatocellular carcinomas, in the cirrhotic liver.
    Yoshikawa T; Hirota S; Matsumoto S; Izaki K; Fukuda T; Sugimura K; Maeda S; Kitagaki H
    Radiat Med; 2002; 20(1):33-6. PubMed ID: 12002601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.